Dr. Douglas Levine is a leader in the field of gynecologic oncology. He specializes in the surgical treatment of women with known or suspected ovarian and endometrial cancers at NYU Langone Health. In his laboratory at NYU, he focuses on precision medicine, rare tumors, and early detection and prevention of gynecologic cancers. They are currently leading the development of national clinical trials for ovarian cancer prevention.
He has authored or coauthored more than 160 peer-reviewed research papers, reviewed articles, and book chapters. He is the founding editor of Atlas of Procedures in Gynecologic Oncology, and he serves on the scientific advisory committee of the Ovarian Cancer Research Fund and the Clearity Foundation.
He is also a special advisor to the board of directors of the Honorable Tina Brozman Foundation and the Co-Chair of the Ovarian Cancer, Endometrial Cancer, and Uterine Carcinosarcoma Working Groups for The Cancer Genome Atlas. He received the Mentor Award from the American Congress of Obstetricians and Gynecologists in 2012 and the Foundation for Women’s Cancer’s Excellence in Ovarian Cancer Research Prize in 2013.